ACSL3 and ovarian cancer: Recent studies have demonstrated significant up-regulation of ACSL1 and ACSL3 protein levels in highly metastatic ovarian cancer cell lines, with gene expression associated with increased metastatic capacity and poor survival prognosis (60).